公司資料
Exagen 股價、新聞與催化劑
- 股票代碼:
- XGN
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
6.70 USD (+0.60%)
收盤價
最後更新: 2026年8月17日
116M USD
市值
股價為何變動
As of Aug 17, 2026, XGN closed up 0.60% at $6.70. No new same-company headline was identified in the current news window.
公司概覽
Autoimmune Diagnostics
Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management.
AVISE CTD
AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines multiple biomarkers into an integrated result intended to improve diagnostic confidence. Exagen operates a centralized clinical laboratory and markets its AVISE portfolio primarily to rheumatologists. Revenue is generated through reimbursed testing, supported by payer coverage and physician adoption.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。